Despite the firm’s test and trace failings, boss Rupert Soames’s £4.9m package is set to be approved by well-rewarded investors
What do you do when your company finds itself at the centre of a controversy? Some companies draw up delicately worded apologies or at least look for convenient scapegoats, but Serco has taken the more traditional approach during the pandemic: stick to your position and insist there’s nothing to see here.
The outsourcing company will be winning no popularity prizes any time soon, not least because of its role in the UK’s expensive test-and-trace programme. The National Audit Office said there was no evidence the £22bn programme had reduced rates of Covid-19 in England.
